About Endoprosthesis
The endoprosthesis (implanted prosthesis) is an artificial joint to replace the functions of the particular body part after losing its functionality. These artificial hips are used as surgical therapy for cases of severe degenerative joint disorders in order to restore the ability to move without any discomfort or pain. Endoprosthesis is used depending on the severity of the damage.
Attributes | Details |
---|
Study Period | 2018-2030 |
Base Year | 2023 |
Unit | Value (USD Million) |
The companies are exploring the market by adopting mergers & acquisitions, expansions, investments, new service launches and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions to avail a competitive advantage through combined synergies. Analyst at AMA Research estimates that United States Players will contribute the maximum growth to Global Endoprosthesis market throughout the forecasted period. Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.
Zimmer Biomet (United States), Stryker (United States), Boston Scientific (United States), Gore Medical (United States), Wright Medical Group, Inc. (United States), BARD Peripheral Vascular Inc. (United States), Fillauer Companies, Inc. (United States) and Smith & Nephew plc (England) are some of the key players that are part of study coverage.
Segmentation Overview
AMA Research has segmented the market of Global Endoprosthesis market by Type (Stent Endoprosthesis, Biliary Endoprosthesis, Upper extremity Endoprosthesis, Lower extremity Endoprosthesis and Dental Endoprosthesis) and Region.
On the basis of geography, the market of Endoprosthesis has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by Material , the sub-segment i.e. Polyethylene (very hard plastic) will boost the Endoprosthesis market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Coating, the sub-segment i.e. Cementless will boost the Endoprosthesis market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by End User, the sub-segment i.e. Hospital will boost the Endoprosthesis market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.
Influencing Trend:
Growing Use of Endoprosthesis in Children and Continuous Research and Development in Medical Devices for Joint Replacement
Market Growth Drivers:
Increasing Joint Replacement Problems in Aged People and Growing Bone Tumors and Cancers
Challenges:
Problems with Improper Sealed Endoprosthesis
Restraints:
Adverse Health Effects Associated with Endoprosthesis Device and High-Cost of Endoprosthesis Device
Opportunities:
Improving the Efficiency of Endoprosthesis device Proper Usage and Availability of Endoprosthesis in various Sizes and Improving its Flexibility and Compression Resistance
Market Leaders and their expansionary development strategies
September 23, 2020—Gore & Associates announced the launch of the lower-profile, large-diameter Gore Viabahn endoprosthesis in the United States. This lower-profile Viabahn design reduces the delivery profile for larger 9- to 13-mm–diameter stent grafts by up to 3 F, which allows for delivery through smaller sheaths.
In January 2021, W. L. Gore & Associates, Inc. (Gore) announces U.S. Food and Drug Administration (FDA) has granted regulatory approval for the new GORE® EXCLUDER® Conformable AAA Endoprosthesis with ACTIVE CONTROL System, a new EVAR solution which builds on the proven clinical performance of the GORE® EXCLUDER® AAA Device and incorporates design elements similar to the Conformable GORE® TAG® Stent Graft.
Food and Drug Administration (FDA) has approved the regulatory standard regarding the commercial distribution of GORE TAG Comfortable Thoracic Stent Graft with the ACTIVE CONTROL System providing a new level of control, two-stage deployment. This design allows continuous blood flow through the deployment and provides angulation for the improved seal, opposition and comfort.
Key Target Audience
Endoprosthesis Manufacturers, Endoprosthesis Distributors and Suppliers, Endoprosthesis International Traders, Research and Development Institutes, Financial Investors and Venture Capital, Regulatory Bodies, Hospitals and Others
About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have a better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with the purpose to understand the companies positioning regarding the market value, volume, and their market share for regional as well as global.
Further to bring relevance specific to any niche market we set and apply a number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders, etc., and work towards appointment generation.
The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, the analyst team keeps preparing a set of questionnaires, and after getting the appointee list; the target audience is then tapped and segregated with various mediums and channels that are feasible for making connections that including email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey, etc.